期刊
REVISTA ESPANOLA DE ANESTESIOLOGIA Y REANIMACION
卷 57, 期 3, 页码 181-184出版社
ELSEVIER SCIENCE BV
DOI: 10.1016/S0034-9356(10)70194-8
关键词
Myasthenia gravis; Sugammadex; Rocuronium; Neuromuscular blockade; Reversal drug
A neuromuscular blocking drug (NMBD) induced neuromuscular blockade (NMB) in patients with myasthenia gravis usually dissipates either spontaneously or by administration of neostigmine. We administered sugammadex to a patient with myasthenia gravis to reverse a rocuronium-induced profound NMB. NMBDs predispose such patients to severe postoperative residual paralysis and respiratory complications. Sugammadex binds steroidal NMBDs and, therefore reverses a rocuronium or vecuronium-induced NMB, without interfering with cholinergic transmission. A rapid and complete recovery from profound NMB was achieved and no adverse events were observed. This case suggests that sugammadex is a safe and effective antagonist of a rocuronium induced NMB blockade in patients with myasthenia gravis.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据